Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	hemoglobin alpha binding	HBB HBD HBG1 HBG2	2.13e-08	5	163	4	GO:0031721
GeneOntologyMolecularFunction	haptoglobin binding	HBB HBD HBG1 HBG2	8.65e-07	10	163	4	GO:0031720
GeneOntologyMolecularFunction	hemoglobin binding	HBB HBD HBG1 HBG2	1.35e-06	11	163	4	GO:0030492
GeneOntologyMolecularFunction	oxygen carrier activity	HBB HBD HBG1 HBG2	4.02e-06	14	163	4	GO:0005344
GeneOntologyMolecularFunction	selenide, water dikinase activity	SEPHS2 SEPHS1	6.62e-05	2	163	2	GO:0004756
GeneOntologyMolecularFunction	phosphotransferase activity, paired acceptors	SEPHS2 SEPHS1	6.62e-05	2	163	2	GO:0016781
GeneOntologyMolecularFunction	hemoglobin beta binding	HBB HBD	6.62e-05	2	163	2	GO:0031722
GeneOntologyMolecularFunction	procollagen glucosyltransferase activity	PLOD1 PLOD2	1.98e-04	3	163	2	GO:0033823
GeneOntologyMolecularFunction	procollagen-lysine 5-dioxygenase activity	PLOD1 PLOD2	1.98e-04	3	163	2	GO:0008475
GeneOntologyMolecularFunction	oxygen binding	HBB HBD HBG1 HBG2	2.29e-04	37	163	4	GO:0019825
GeneOntologyMolecularFunction	N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity	CHSY1 CHPF	3.93e-04	4	163	2	GO:0050510
GeneOntologyMolecularFunction	N-acetylmuramoyl-L-alanine amidase activity	PGLYRP4 PGLYRP3	3.93e-04	4	163	2	GO:0008745
GeneOntologyMolecularFunction	peptidyl-lysine 5-dioxygenase activity	PLOD1 PLOD2	3.93e-04	4	163	2	GO:0070815
GeneOntologyMolecularFunction	synaptic receptor adaptor activity	SHANK1 SHANK3	3.93e-04	4	163	2	GO:0030160
GeneOntologyMolecularFunction	peptidoglycan immune receptor activity	PGLYRP4 PGLYRP3	6.52e-04	5	163	2	GO:0016019
GeneOntologyMolecularFunction	glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity	CHSY1 CHPF	9.72e-04	6	163	2	GO:0047238
GeneOntologyMolecularFunction	ankyrin repeat binding	SHANK1 TNKS1BP1	1.35e-03	7	163	2	GO:0071532
GeneOntologyMolecularFunction	kinase activity	LMTK2 HKDC1 DGKQ DGKE LMTK3 PTK6 FN3K TXK SBK1 MST1 JAK3 STK10 SEPHS2 SEPHS1 TAF1L	1.52e-03	764	163	15	GO:0016301
GeneOntologyMolecularFunction	oxidoreductase activity	FMO2 PDHB CYP20A1 NDUFV1 ADH5 DECR1 HSD17B4 HBB HBD PLOD1 HBG1 PLOD2 HBG2 TET3 HR	1.56e-03	766	163	15	GO:0016491
GeneOntologyBiologicalProcess	oxygen transport	HBB HBD HBG1 HBG2	4.24e-06	15	158	4	GO:0015671
GeneOntologyBiologicalProcess	carbon dioxide transport	HBB HBD HBG1 HBG2	1.17e-05	19	158	4	GO:0015670
GeneOntologyBiologicalProcess	gas transport	HBB HBD HBG1 HBG2	4.35e-05	26	158	4	GO:0015669
GeneOntologyBiologicalProcess	selenocysteine biosynthetic process	SEPHS2 SEPHS1	5.83e-05	2	158	2	GO:0016260
GeneOntologyCellularComponent	haptoglobin-hemoglobin complex	HBB HBD HBG1 HBG2	1.60e-06	12	161	4	GO:0031838
GeneOntologyCellularComponent	hemoglobin complex	HBB HBD HBG1 HBG2	1.60e-06	12	161	4	GO:0005833
GeneOntologyCellularComponent	ciliary pocket membrane	EHD3 EHD1	1.76e-04	3	161	2	GO:0020018
GeneOntologyCellularComponent	ciliary pocket	EHD3 EHD1	1.76e-04	3	161	2	GO:0020016
GeneOntologyCellularComponent	UBC13-MMS2 complex	UBE2V1 UBE2V2	3.50e-04	4	161	2	GO:0031372
HumanPheno	Increased red cell sickling tendency	HBB HBG1 HBG2	5.94e-06	5	44	3	HP:0008346
HumanPheno	HbS hemoglobin	HBB HBG1 HBG2	5.94e-06	5	44	3	HP:0045047
HumanPheno	Splenic infarction	HBB HBG1 HBG2	2.05e-05	7	44	3	HP:0034336
HumanPheno	Microcytic anemia	SLC35C1 HBB HBD HBG1 HBG2	5.48e-05	49	44	5	HP:0001935
Domain	WD40_repeat	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 HERC2 WDR77 DYNC1I1	1.41e-08	272	161	15	IPR001680
Domain	WD_REPEATS_1	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 HERC2 WDR77 DYNC1I1	1.89e-08	278	161	15	PS00678
Domain	WD_REPEATS_2	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 HERC2 WDR77 DYNC1I1	1.99e-08	279	161	15	PS50082
Domain	WD_REPEATS_REGION	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 HERC2 WDR77 DYNC1I1	1.99e-08	279	161	15	PS50294
Domain	Haemoglobin_b	HBB HBD HBG1 HBG2	2.64e-08	5	161	4	IPR002337
Domain	WD40	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	5.63e-08	259	161	14	PF00400
Domain	WD40	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	8.61e-08	268	161	14	SM00320
Domain	WD40_repeat_CS	GRWD1 COPA EML6 WDR83 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 WDR77	1.83e-07	164	161	11	IPR019775
Domain	WD40_repeat_dom	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	3.03e-07	297	161	14	IPR017986
Domain	-	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	1.19e-06	333	161	14	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	1.28e-06	335	161	14	IPR015943
Domain	Globin	HBB HBD HBG1 HBG2	2.50e-06	12	161	4	IPR000971
Domain	Globin	HBB HBD HBG1 HBG2	2.50e-06	12	161	4	PF00042
Domain	GLOBIN	HBB HBD HBG1 HBG2	2.50e-06	12	161	4	PS01033
Domain	-	HBB HBD HBG1 HBG2	3.58e-06	13	161	4	1.10.490.10
Domain	Globin/Proto	HBB HBD HBG1 HBG2	3.58e-06	13	161	4	IPR012292
Domain	Globin-like	HBB HBD HBG1 HBG2	8.93e-06	16	161	4	IPR009050
Domain	SH3_2	SHANK1 ARHGEF5 ITSN1 SHANK3 PTK6 MIA2 FCHSD1	9.42e-06	86	161	7	PF07653
Domain	SH3_2	SHANK1 ARHGEF5 ITSN1 SHANK3 PTK6 MIA2 FCHSD1	9.42e-06	86	161	7	IPR011511
Domain	HELP	EML6 EML5 EML1	1.23e-05	6	161	3	PF03451
Domain	HELP	EML6 EML5 EML1	1.23e-05	6	161	3	IPR005108
Domain	Apc4_WD40_dom	COPA EML6 EML5 CORO6	2.31e-05	20	161	4	IPR024977
Domain	ANAPC4_WD40	COPA EML6 EML5 CORO6	2.31e-05	20	161	4	PF12894
Domain	Chond_GalNAc	CHSY1 B4GALNT3 CHPF	3.41e-05	8	161	3	IPR008428
Domain	CHGN	CHSY1 B4GALNT3 CHPF	3.41e-05	8	161	3	PF05679
Domain	EF-hand_4	ITSN1 EHD3 EHD1	7.22e-05	10	161	3	PF12763
Domain	ARHGEF5_35	ARHGEF5 ARHGEF35	7.39e-05	2	161	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF5 ARHGEF35	7.39e-05	2	161	2	IPR029212
Domain	SPS/SelD	SEPHS2 SEPHS1	7.39e-05	2	161	2	IPR004536
Domain	EHD1/EHD3	EHD3 EHD1	7.39e-05	2	161	2	IPR029951
Domain	EH	ITSN1 EHD3 EHD1	9.86e-05	11	161	3	PS50031
Domain	EH	ITSN1 EHD3 EHD1	9.86e-05	11	161	3	SM00027
Domain	EH_dom	ITSN1 EHD3 EHD1	9.86e-05	11	161	3	IPR000261
Domain	-	PKHD1L1 B4GALNT3	2.20e-04	3	161	2	3.90.182.10
Domain	PA14	PKHD1L1 B4GALNT3	2.20e-04	3	161	2	SM00758
Domain	PA14	PKHD1L1 B4GALNT3	2.20e-04	3	161	2	PF07691
Domain	PA14_dom	PKHD1L1 B4GALNT3	2.20e-04	3	161	2	IPR011658
Domain	TECPR	HERC2 TECPR1	2.20e-04	3	161	2	SM00706
Domain	Procol_lys_dOase	PLOD1 PLOD2	2.20e-04	3	161	2	IPR001006
Domain	-	SEPHS2 SEPHS1	2.20e-04	3	161	2	3.90.650.10
Domain	LYS_HYDROXYLASE	PLOD1 PLOD2	2.20e-04	3	161	2	PS01325
Domain	Beta-propeller_rpt_TECPR	HERC2 TECPR1	2.20e-04	3	161	2	IPR006624
Domain	Amidase_domain	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	IPR002502
Domain	PGRP	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	SM00701
Domain	Amidase_2	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	PF01510
Domain	Mib_Herc2	HERC2 HECTD1	4.38e-04	4	161	2	IPR010606
Domain	FERM_f0	SHANK1 SHANK3	4.38e-04	4	161	2	PF16511
Domain	MIB_HERC2	HERC2 HECTD1	4.38e-04	4	161	2	PS51416
Domain	MIB_HERC2	HERC2 HECTD1	4.38e-04	4	161	2	PF06701
Domain	-	SEPHS2 SEPHS1	4.38e-04	4	161	2	3.30.1330.10
Domain	Ami_2	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	SM00644
Domain	AIRS_C	SEPHS2 SEPHS1	4.38e-04	4	161	2	PF02769
Domain	-	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	3.40.80.10
Domain	AIRS	SEPHS2 SEPHS1	4.38e-04	4	161	2	PF00586
Domain	PurM-like_N	SEPHS2 SEPHS1	4.38e-04	4	161	2	IPR016188
Domain	FERM_f0	SHANK1 SHANK3	4.38e-04	4	161	2	IPR032425
Domain	AIR_synth_C_dom	SEPHS2 SEPHS1	4.38e-04	4	161	2	IPR010918
Domain	PGRP_domain_met/bac	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	IPR006619
Domain	PGRP	PGLYRP4 PGLYRP3	4.38e-04	4	161	2	IPR015510
Domain	SH3_domain	SHANK1 ARHGEF5 ITSN1 SHANK3 PTK6 TXK MIA2 FCHSD1	6.56e-04	220	161	8	IPR001452
Domain	EHD_N	EHD3 EHD1	7.26e-04	5	161	2	IPR031692
Domain	EHD_N	EHD3 EHD1	7.26e-04	5	161	2	PF16880
Domain	G-protein_beta_WD-40_rep	GRWD1 COPA WDR83 WDFY2 WDR41	8.42e-04	85	161	5	IPR020472
Domain	Kinesin_assoc	KIF13B KIF1C	1.08e-03	6	161	2	PF16183
Domain	Haem_d1	COPA EML6	1.08e-03	6	161	2	IPR011048
Domain	Kinesin_assoc	KIF13B KIF1C	1.08e-03	6	161	2	IPR032405
Domain	PROTEIN_KINASE_TYR	LMTK2 LMTK3 PTK6 TXK JAK3	1.52e-03	97	161	5	PS00109
Domain	-	SHANK1 CNKSR1 PDLIM7 SHANK3 TIAM1 AHNAK	1.93e-03	150	161	6	2.30.42.10
Domain	FYVE	WDFY2 ZFYVE28 WDFY3	1.95e-03	29	161	3	PF01363
Domain	FYVE	WDFY2 ZFYVE28 WDFY3	1.95e-03	29	161	3	SM00064
Domain	PDZ	SHANK1 CNKSR1 PDLIM7 SHANK3 TIAM1 AHNAK	1.99e-03	151	161	6	PS50106
Domain	PDZ	SHANK1 CNKSR1 PDLIM7 SHANK3 TIAM1 AHNAK	2.06e-03	152	161	6	IPR001478
Domain	SH3	SHANK1 ARHGEF5 ITSN1 SHANK3 PTK6 TXK FCHSD1	2.73e-03	216	161	7	SM00326
Domain	SH3	SHANK1 ARHGEF5 ITSN1 SHANK3 PTK6 TXK FCHSD1	2.73e-03	216	161	7	PS50002
Domain	Znf_FYVE-rel	WDFY2 ZFYVE28 WDFY3	3.09e-03	34	161	3	IPR017455
Domain	DAGK_acc	DGKQ DGKE	3.18e-03	10	161	2	PF00609
Domain	Diacylglycerol_kin_accessory	DGKQ DGKE	3.18e-03	10	161	2	IPR000756
Domain	DAGKa	DGKQ DGKE	3.18e-03	10	161	2	SM00045
Domain	Laminin_G_1	HSPG2 CSPG4	3.86e-03	11	161	2	PF00054
Domain	Znf_FYVE	WDFY2 ZFYVE28 WDFY3	4.25e-03	38	161	3	IPR000306
Domain	LAM_G_DOMAIN	HSPG2 FAT3 CSPG4	4.25e-03	38	161	3	PS50025
Domain	GDS_CDC24_CS	ARHGEF5 ITSN1 TIAM1	4.58e-03	39	161	3	IPR001331
Domain	ZF_FYVE	WDFY2 ZFYVE28 WDFY3	4.92e-03	40	161	3	PS50178
Domain	Laminin_G_2	HSPG2 FAT3 CSPG4	4.92e-03	40	161	3	PF02210
Domain	G_DYNAMIN_dom	EHD3 EHD1	6.28e-03	14	161	2	IPR030381
Domain	DAGKc	DGKQ DGKE	6.28e-03	14	161	2	SM00046
Domain	G_DYNAMIN_2	EHD3 EHD1	6.28e-03	14	161	2	PS51718
Domain	LamG	HSPG2 FAT3 CSPG4	6.43e-03	44	161	3	SM00282
Domain	Nucleotide-diphossugar_trans	CHSY1 B4GALNT3 PLOD1 PLOD2	7.08e-03	88	161	4	IPR029044
Domain	Diacylglycerol_kinase_cat_dom	DGKQ DGKE	7.20e-03	15	161	2	IPR001206
Domain	Dynamin_GTPase	EHD3 EHD1	7.20e-03	15	161	2	IPR001401
Domain	DAGK	DGKQ DGKE	7.20e-03	15	161	2	PS50146
Domain	Dynamin_SF	EHD3 EHD1	7.20e-03	15	161	2	IPR022812
Domain	N2O_reductase_N	EML1 WDR77	7.20e-03	15	161	2	IPR011045
Domain	Dynamin_N	EHD3 EHD1	7.20e-03	15	161	2	PF00350
Domain	DAGK_cat	DGKQ DGKE	7.20e-03	15	161	2	PF00781
Domain	PDZ	SHANK1 PDLIM7 SHANK3 TIAM1 AHNAK	7.56e-03	141	161	5	PF00595
Domain	P4Hc	PLOD1 PLOD2	8.19e-03	16	161	2	SM00702
Domain	Pro_4_hyd_alph	PLOD1 PLOD2	8.19e-03	16	161	2	IPR006620
Pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	KIF13B ZFPM2 EHD3 EHD1 HBB HBD HBG1 HBG2 KIF1C	2.29e-05	170	127	9	M941
Pubmed	The mouse globin pseudogene beta h3 is descended from a premammalian delta-globin gene.	HBB HBD HBG1 HBG2	5.01e-10	4	166	4	6092350
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 PCNX3 IPP LMTK2 CHSY1 DGKQ PPP6R1 WRAP53 TEP1 RYR1 CNPPD1 JAK3 STK10 SEPHS2 AHNAK CSPG4 ENTPD2 USP40 TNKS1BP1 WDFY3 HERC2 CHPF HECTD1 HR	6.44e-10	1105	166	24	35748872
Pubmed	Extensive movement of LINES ONE sequences in beta-globin loci of Mus caroli and Mus domesticus.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2905421
Pubmed	An intron nucleotide sequence variant in a cloned beta +-thalassaemia globin gene.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6264391
Pubmed	A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	7151176
Pubmed	The 3' splice site of pre-messenger RNA is recognized by a small nuclear ribonucleoprotein.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2933810
Pubmed	Direct sequencing of enzymatically amplified human genomic DNA.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3267215
Pubmed	A fusion gene in man: DNA sequence analysis of the abnormal globin gene of hemoglobin Miyada.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6324786
Pubmed	mRNA precursor splicing in vivo: sequence requirements determined by deletion analysis of an intervening sequence.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3857622
Pubmed	A naturally occurring deletion in the mouse Hbbs beta-globin gene cluster.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3459181
Pubmed	G to A substitution in the distal CCAAT box of the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2578619
Pubmed	A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2578620
Pubmed	Duplication followed by deletion accounts for the structure of an Indian deletion beta (0)-thalassemia gene.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	7162987
Pubmed	A weak upstream promoter gives rise to long human beta-globin RNA molecules.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6303333
Pubmed	Beta + thalassemia: aberrant splicing results from a single point mutation in an intron.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6895866
Pubmed	Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	7557375
Pubmed	The beta-globin gene in Sardinian delta beta 0-thalassemia carries a C----T nonsense mutation at codon 39.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6327288
Pubmed	beta-Thalassemia present in cis to a new beta-chain structural variant, Hb Vicksburg [beta 75 (E19)Leu leads to 0].	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6165992
Pubmed	beta zero thalassemia in Sardinia is caused by a nonsense mutation.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6457059
Pubmed	mRNA-deficient beta o-thalassemia results from a single nucleotide deletion.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6292840
Pubmed	Epsilon globin gene transcripts originating upstream of the mRNA cap site in K562 cells and normal human embryos.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6292831
Pubmed	Unexpected relationships between four large deletions in the human beta-globin gene cluster.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6652684
Pubmed	Cloning specific complete polyadenylylated 3'-terminal cDNA segments.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2581851
Pubmed	Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	873928
Pubmed	beta 0 thalassemia, a nonsense mutation in man.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	88735
Pubmed	Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3879973
Pubmed	The "beta-like-globin" gene domain in human erythroid cells.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3879975
Pubmed	Molecular characterization of seven beta-thalassemia mutations in Asian Indians.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6714226
Pubmed	Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6086605
Pubmed	Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6280057
Pubmed	A nucleotide change at a splice junction in the human beta-globin gene is associated with beta 0-thalassemia.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6270663
Pubmed	Hemoglobin Long Island is caused by a single mutation (adenine to cytosine) resulting in a failure to cleave amino-terminal methionine.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3455755
Pubmed	Alternative sites of transcription initiation upstream of the canonical cap site in human gamma-globin and beta-globin genes.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6701091
Pubmed	Human fetal globin DNA sequences suggest novel conversion event.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6330670
Pubmed	Beta-thalassemia due to a T----A mutation within the ATA box.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	3382401
Pubmed	Developmental regulation of a complete 70-kb human beta-globin locus in transgenic mice.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	1383089
Pubmed	Nucleotide sequence of the BALB/c mouse beta-globin complex.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	2926808
Pubmed	The deletion in a type of delta 0-beta 0-thalassaemia begins in an inverted AluI repeat.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6184621
Pubmed	The structure and expression of the haemoglobin genes.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6297279
Pubmed	Nonsense and frameshift mutations in beta 0-thalassemia detected in cloned beta-globin genes.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6985481
Pubmed	Nonsense mutation as a cause of beta 0 thalassemia.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6985475
Pubmed	Identification of a retrovirus-like repetitive element in human DNA.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6095301
Pubmed	A transient definitive erythroid lineage with unique regulation of the β-globin locus in the mammalian embryo.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	21378272
Pubmed	A molecular study of a family with Greek hereditary persistence of fetal hemoglobin and beta-thalassemia.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6210198
Pubmed	Structure and expression of a cloned beta o thalassaemic globin gene.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6272205
Pubmed	Transcriptional interference among the murine beta-like globin genes.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	17077320
Pubmed	Molecular cloning and characterization of the human beta-like globin gene cluster.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6155216
Pubmed	DNA sequence organization of the beta-globin complex in the BALB/c mouse.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6250710
Pubmed	Multiple origins of transcription in the 4.5 Kb upstream of the epsilon-globin gene.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6194897
Pubmed	Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	8649401
Pubmed	Human beta-globin promoter and coding sequences transcribed by RNA polymerase III.	HBB HBD HBG1 HBG2	2.49e-09	5	166	4	6194893
Pubmed	"Maturational" globin switching in primary primitive erythroid cells.	HBB HBD HBG1 HBG2	7.45e-09	6	166	4	16263786
Pubmed	Multiple hematopoietic defects and delayed globin switching in Ikaros null mice.	HBB HBD HBG1 HBG2	7.45e-09	6	166	4	11805317
Pubmed	The structure and evolution of the human beta-globin gene family.	HBB HBD HBG1 HBG2	7.45e-09	6	166	4	6985477
Pubmed	Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells.	HBB HBD HBG1 HBG2	7.45e-09	6	166	4	17655922
Pubmed	A novel strategy to identify maternal and paternal inheritance in the mouse.	HBB HBD HBG1 HBG2	7.45e-09	6	166	4	7588571
Pubmed	ZNF410 represses fetal globin by singular control of CHD4.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	33859416
Pubmed	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	21127173
Pubmed	Developmental and species-divergent globin switching are driven by BCL11A.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	19657335
Pubmed	Strict in vivo specificity of the Bcl11a erythroid enhancer.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	27707736
Pubmed	Early mammalian erythropoiesis requires the Dot1L methyltransferase.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	20798234
Pubmed	Sox6 directly silences epsilon globin expression in definitive erythropoiesis.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	16462943
Pubmed	Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci.	HBB HBD HBG1 HBG2	1.73e-08	7	166	4	9887104
Pubmed	Cis-regulatory mechanisms governing stem and progenitor cell transitions.	HBB HBD HBG1 HBG2	3.45e-08	8	166	4	26601269
Pubmed	Targeted deletion of Nm23/nucleoside diphosphate kinase A and B reveals their requirement for definitive erythropoiesis in the mouse embryo.	HBB HBD HBG1 HBG2	3.45e-08	8	166	4	19235734
Pubmed	UCP2 modulates cell proliferation through the MAPK/ERK pathway during erythropoiesis and has no effect on heme biosynthesis.	HBB HBD HBG1 HBG2	3.45e-08	8	166	4	18687678
Pubmed	Real-time PCR for single-cell genotyping in sickle cell and thalassemia syndromes as a rapid, accurate, reliable, and widely applicable protocol for preimplantation genetic diagnosis.	HBB HBD HBG1 HBG2	3.45e-08	8	166	4	15108284
Pubmed	Poly(C)-Binding Protein Pcbp2 Enables Differentiation of Definitive Erythropoiesis by Directing Functional Splicing of the Runx1 Transcript.	HBB HBD HBG1 HBG2	3.45e-08	8	166	4	29866654
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SHANK1 MKRN3 CNKSR1 COPA PDHB ITSN1 WRAP53 LRP1B FN3K SPTBN4 CNPPD1 MIA2 STX18 DAZAP1 TIAM1 SUPT5H DHX35 WDFY3 HERC2 HSD17B4 CHPF HECTD1 DYNC1I1	5.43e-08	1285	166	23	35914814
Pubmed	Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	7753194
Pubmed	Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	7926723
Pubmed	A mutant mouse with severe anemia and skin abnormalities controlled by a new allele of the flaky skin (fsn) locus.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	16093647
Pubmed	Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	19740759
Pubmed	3' non-coding region sequences in eukaryotic messenger RNA.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	822353
Pubmed	Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	12619131
Pubmed	Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	23716600
Pubmed	Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	9887098
Pubmed	Role of the GATA-1/FOG-1/NuRD pathway in the expression of human beta-like globin genes.	HBB HBD HBG1 HBG2	6.19e-08	9	166	4	20439494
Pubmed	KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic beta-like globin genes in vivo.	HBB HBD HBG1 HBG2	1.03e-07	10	166	4	15947087
Pubmed	Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse.	HBB HBD HBG1 HBG2	1.03e-07	10	166	4	10529424
Pubmed	SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis.	HBB HBD HBG1 HBG2	1.03e-07	10	166	4	14729577
Pubmed	Multilineage hematopoietic progenitor activity generated autonomously in the mouse yolk sac: analysis using angiogenesis-defective embryos.	HBB HBD HBG1 HBG2	1.03e-07	10	166	4	12755332
Pubmed	Differential segregation of beta+ IVS-I-110 (G --> A), A(gamma) -117 (G-->A), and G(gamma) -158 (C --> T) mutations in members of an Albanian family.	HBB HBG1 HBG2	1.07e-07	3	166	3	14649320
Pubmed	Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.	HBB HBD HBG1 HBG2	1.61e-07	11	166	4	7753195
Pubmed	Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor.	HBB HBD HBG1 HBG2	1.61e-07	11	166	4	8799165
Pubmed	TAF10 Interacts with the GATA1 Transcription Factor and Controls Mouse Erythropoiesis.	HBB HBD HBG1 HBG2	2.40e-07	12	166	4	25870109
Pubmed	A critical role for endoglin in the emergence of blood during embryonic development.	HBB HBD HBG1 HBG2	2.40e-07	12	166	4	22535663
Pubmed	A review of the molecular genetics of the human alpha-globin gene cluster.	HBB HBD HBG1 HBG2	2.40e-07	12	166	4	2649166
Pubmed	Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo.	HBB HBD HBG1 HBG2	2.40e-07	12	166	4	9811585
Pubmed	Variegated gene expression caused by cell-specific long-range DNA interactions.	HBB HBD HBG1 HBG2	2.40e-07	12	166	4	21706023
Pubmed	POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.	HBB HBD HBG1 HBG2	3.46e-07	13	166	4	29898395
Pubmed	Defective erythropoiesis in transgenic mice expressing dominant-negative upstream stimulatory factor.	HBB HBD HBG1 HBG2	3.46e-07	13	166	4	19704006
Pubmed	Conservation of sequence and structure flanking the mouse and human beta-globin loci: the beta-globin genes are embedded within an array of odorant receptor genes.	HBB HBD HBG1 HBG2	6.56e-07	15	166	4	10220430
Pubmed	HIC2 regulates isoform switching during maturation of the cardiovascular system.	HBB HBD HBG1 HBG2	8.71e-07	16	166	4	29061339
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SHANK1 CACNA1A KIF13B ITSN1 TNRC6B PPP6R1 LMTK3 GRM2 SHANK3 FBXO2 EHD3 SPTBN4 UBE2V1 UBE2V2 PPP1R3F WDFY3 EML1 HERC2	9.21e-07	963	166	18	28671696
Pubmed	Subtractive hybridization reveals tissue-specific expression of ahnak during embryonic development.	AHNAK HBG1 HBG2	1.06e-06	5	166	3	11284963
Pubmed	Membrane interactions of hemoglobin variants, HbA, HbE, HbF and globin subunits of HbA: effects of aminophospholipids and cholesterol.	HBB HBG1 HBG2	1.06e-06	5	166	3	17916326
Pubmed	A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development.	HBB HBD HBG1 HBG2	1.13e-06	17	166	4	16287714
Pubmed	EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts.	HBB HBD HBG1 HBG2	1.13e-06	17	166	4	37042948
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	IGSF8 HSPG2 MAN2A1 COPA ARFGEF1 CHSY1 PPP6R1 LRP1B MIA2 PRCP CSPG4 EDEM2 TNKS1BP1 CHID1 CHPF PLOD1 HECTD1 PLOD2 ATP2B1 NAXE	1.32e-06	1201	166	20	35696571
Interaction	RAB11FIP2 interactions	KIF13B ITSN1 SHANK3 EHD3 JAK3 CBY1 EHD1	5.35e-06	83	165	7	int:RAB11FIP2
Cytoband	11p15.5	CHID1 HBB HBD HBG1 HBG2	7.32e-05	118	166	5	11p15.5
GeneFamily	WD repeat domain containing	GRWD1 COPA EML6 WDR83 WRAP53 TEP1 WDFY2 EML5 CORO6 WDR41 WDFY3 EML1 WDR77 DYNC1I1	7.65e-10	262	111	14	362
GeneFamily	Hemoglobin subunits	HBB HBD HBG1 HBG2	2.75e-07	10	111	4	940
GeneFamily	Beta 4-glycosyltransferases	CHSY1 B4GALNT3 CHPF	1.44e-04	17	111	3	425
GeneFamily	PDZ domain containing	SHANK1 CNKSR1 PDLIM7 SHANK3 TIAM1 AHNAK	3.50e-04	152	111	6	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF5 ITSN1 ARHGEF35 TIAM1	7.24e-04	66	111	4	722
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	7.69e-04	7	111	2	570
GeneFamily	Zinc fingers FYVE-type\|Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors	WDFY2 ZFYVE28 WDFY3	8.93e-04	31	111	3	81
GeneFamily	EF-hand domain containing\|Diacylglycerol kinases	DGKQ DGKE	1.63e-03	10	111	2	1178
ToppCell	severe-Myeloid-Neutrophils_4\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HBD MSL1 JAK3 SLC12A9 WDFY3 HBB HBG1 HBG2	8.83e-07	199	167	8	50242666def13e5d4149c563ae000d6768f086f7
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SHANK1 HKDC1 ZFPM2 ZFYVE28 EML5 CORO6 ATP2B1	1.54e-06	149	167	7	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SHANK1 LMTK2 LMTK3 SHANK3 SBK1 ZFYVE28 CORO6	3.29e-06	167	167	7	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	SHANK1 LMTK2 LMTK3 SHANK3 SBK1 ZFYVE28 CORO6	3.29e-06	167	167	7	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	normal-na-Lymphocytic_B-B_plasma-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	HSPG2 CNKSR1 EML6 GPRC5C PKHD1L1 BRCA2 CHPF	3.70e-06	170	167	7	c5b87974dfddf9780051f7f5693eeeb0c606a3fe
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 SLC35C1 DGKE ZFPM2 TG PRCP EML1	4.31e-06	174	167	7	6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d
ToppCell	IIH-CD8-CD4_Treg\|IIH / Condition, Cell_class and T cell subcluster	TOPBP1 LMTK2 C20orf204 HKDC1 FBXO2 BRCA2 HBB	5.39e-06	180	167	7	d1a8b25115c80e5a5bd0b8244167a98250ab9778
ToppCell	10x5'v1-week_17-19-Hematopoietic-erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 FN3K HBB HBD HBG1 HBG2 FOXJ1	6.23e-06	184	167	7	0efc757d9512d6a8fe8176e977a94e4494ed9778
ToppCell	10x3'2.3-week_12-13-Hematopoietic-erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBD HBG1 HBG2	8.22e-06	192	167	7	6ace9a34ed264583042156ed61c2cb3504a331d2
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRP1B ZFPM2 FBXO2 TIAM1 CSPG4 PLOD2 DYNC1I1	1.07e-05	200	167	7	b5a54b9baf79aea01f76a161f0a39bbe87eb4945
ToppCell	COVID-19-COVID-19_Severe-Others-RBC\|COVID-19_Severe / Disease, condition lineage and cell class	TRIM58 ITSN1 HBD CNPPD1 HBB HBG1 HBG2	1.07e-05	200	167	7	308f74e7e13ecc6d133c219c42cc8895a96644c8
ToppCell	Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LRP1B ZFPM2 FBXO2 TIAM1 CSPG4 PLOD2 DYNC1I1	1.07e-05	200	167	7	f5bd0b30e478dac09f68c46b0781f5f2e7e3c693
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRIM58 GRM2 HBB HBD HBG1 HBG2	1.26e-05	136	167	6	94eb78a4b8da307c07c2c4f05b8a14424f887579
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ERICH3 GRM2 TXK HBG1 HBG2 CTSW	1.49e-05	140	167	6	a88dbe7bf3e1419e360ab0b8cf24681d3424c3a7
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|Erythro-cells / Lineage, cell class and subclass	TRIM58 ITSN1 HBD HBB HBG1 HBG2	1.74e-05	144	167	6	7fbedc65314cfb06bcc527d794b5de7858f7c5ec
ToppCell	10x3'2.3-week_12-13-Hematopoietic-erythroid-late_erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 HBB HBD HBG1 HBG2	2.51e-05	92	167	5	3292898c81580e33c82f91b949a86bf4b5297781
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF12 TXK AHNAK PLOD1 CTSW TECPR1	3.05e-05	159	167	6	d2de9391b00b6c47f5fe28a1bad6da2097107ee0
ToppCell	facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNFSF12 TXK AHNAK PLOD1 CTSW TECPR1	3.05e-05	159	167	6	da6b7f8039adc19839d6c090a0b3d68fb6445a79
ToppCell	wk_08-11-Hematologic-Meg-ery-HMOX1+_primitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PGLYRP4 TRIM58 CNPPD1 STX18 HBG1 HBG2	3.27e-05	161	167	6	6079de6cc4f2aec4091d0fac531fda9a441a70b1
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHSY1 LMTK3 TXK STK10 CTSW KIF1C	3.39e-05	162	167	6	0321fc954ae4ad67ca438cbbc84632562d222188
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHSY1 LMTK3 TXK STK10 CTSW KIF1C	3.39e-05	162	167	6	5731f9514434296132df4bc86f78ce87b07cdeca
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRIM58 PKHD1L1 EHD3 HBG1 PLOD2 HBG2	3.75e-05	165	167	6	6799a6580c667738995cceb31cbf1c7fbdc4ff84
ToppCell	PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRIM58 PKHD1L1 EHD3 HBG1 PLOD2 HBG2	3.75e-05	165	167	6	8329d780f244bc31344443b29e5a00529a016662
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	4.73e-05	172	167	6	cc1a45a35f78063b2a777ae905f70f894fbcb22f
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	4.73e-05	172	167	6	f0b658baa4b41329c95a09387cc55ea046e2333f
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	4.73e-05	172	167	6	30c57f5ca2326e8d890d9aac8096c64e5b51a24f
ToppCell	facs-Marrow-T_cells-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO2 TG ZFYVE28 EDEM2 CHID1 CHPF	4.89e-05	173	167	6	e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807
ToppCell	facs-Marrow-KLS-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERICH3 TEX13B LMTK3 TG CHID1 CHPF	4.89e-05	173	167	6	295bfe1efa648173c2d5981025bc61c576baf53f
ToppCell	facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO2 TG ZFYVE28 EDEM2 CHID1 CHPF	5.05e-05	174	167	6	3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IPP SBK1 STK10 KRBA1 PALM3 CTSW	5.05e-05	174	167	6	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IPP SBK1 STK10 KRBA1 PALM3 CTSW	5.05e-05	174	167	6	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBXO2 TG ZFYVE28 EDEM2 CHID1 CHPF	5.21e-05	175	167	6	4be01bf30331162f1998216fb2871a4e626dc440
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	5.21e-05	175	167	6	c33317d8d60ea88ec326daf91dfd3416a62f9938
ToppCell	18-Distal-RBC-RBC\|Distal / Age, Tissue, Lineage and Cell class	TRIM58 HBD HBB HBG1 HBG2 TET3	5.21e-05	175	167	6	7130b816e0c02309c161d8e9ad7cb4bc2469e251
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRID2 ZFPM2 CSPG4 CORO6 SDK1 DYNC1I1	5.21e-05	175	167	6	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRID2 ZFPM2 CSPG4 CORO6 SDK1 DYNC1I1	5.21e-05	175	167	6	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	18-Distal-RBC\|Distal / Age, Tissue, Lineage and Cell class	TRIM58 HBD HBB HBG1 HBG2 TET3	5.21e-05	175	167	6	cc476b4244442418b8f21721a82a36209b556b36
ToppCell	facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML6 FBXO2 TG ZFYVE28 CHPF HR	5.38e-05	176	167	6	5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPRC5C FBXO2 CSPG4 CORO6 B4GALNT3 DYNC1I1	5.38e-05	176	167	6	77c3da2eaa072a6baefb5087fd07ec18c5e271cd
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	5.38e-05	176	167	6	9af82b976e6a14a3ef7aa50f1f7af2463e5aa5d2
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_MEMP\|lymph-node_spleen / Manually curated celltypes from each tissue	HSPG2 TRIM58 SHANK3 HBB HBD PLOD2	5.38e-05	176	167	6	23a8ec42ebd42c539865a12d09773af90f3f8848
ToppCell	facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML6 TG ZFYVE28 CD163L1 EDEM2 HR	5.55e-05	177	167	6	35d42b07d9c31528bf59199e361bb8a3bfbe3b75
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 CYP20A1 EDEM2 CHID1 CHPF PRRC1	5.73e-05	178	167	6	b902059c3f861108fc64cbdc05e6f44378f5be2c
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SHANK3 EHD3 NYNRIN AHNAK DYNC1I1	6.09e-05	180	167	6	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SHANK3 EHD3 NYNRIN AHNAK DYNC1I1	6.09e-05	180	167	6	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	6.28e-05	181	167	6	577bf37a6594fad01251d2c66d8ccda8e949b6cf
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	6.28e-05	181	167	6	f5dc7a650afe8837cb424981e50ad2c8b18c7c32
ToppCell	COVID-19-kidney-Mito-rich_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	ARHGAP30 JAK3 STK10 PLCB2 HBB CTSW	6.28e-05	181	167	6	8448c2ad560cfd48bfe9dc1dd3a64373e6a622dd
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TEP1 SBK1 STK10 MIA2 AHNAK ATP2B1	6.48e-05	182	167	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	6.48e-05	182	167	6	e5e16abf4d3bd5a97e7c573b99f7a3d9a5add120
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 SHANK3 ZFPM2 EHD3 TIAM1 NYNRIN	6.48e-05	182	167	6	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|bone_marrow / Manually curated celltypes from each tissue	TRIM58 PKHD1L1 EHD3 PLOD2 HBG2 DYNC1I1	6.68e-05	183	167	6	3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d
ToppCell	wk_08-11-Hematologic-Meg-ery\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	PGLYRP4 TRIM58 HBB HBD HBG1 HBG2	6.68e-05	183	167	6	7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RYR1 FBXO2 TG EDEM2 CHID1 CHPF	7.09e-05	185	167	6	238938a4682b44e88a30b86b13af4feeabe9553d
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175\|Adult / Lineage, Cell type, age group and donor	ITSN1 CHSY1 RYR1 STK10 CD163L1 WDFY3	7.09e-05	185	167	6	ab5704b96f1d368911308797d10c7c52766ab134
ToppCell	10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	7.09e-05	185	167	6	e9059cefcdf0972ec90793b1dd34c3292b17a061
ToppCell	PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	7.30e-05	186	167	6	3b60a153e6cfc1b977a1f8b8f3bcaf75d1f4ff5b
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHD3 TXK AHNAK CHPF CTSW TECPR1	7.30e-05	186	167	6	4dce1484653bb266e2305cbb306fb11eaf7892e2
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	7.30e-05	186	167	6	1c39ced3b32dba2832991284720b6c5f508a2e73
ToppCell	PCW_07-8.5-Hematologic_ErythroMegGranulo\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	7.30e-05	186	167	6	294839944266407c40ef86e1d3e0fce4652b70ff
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD CNPPD1 HBB HBG1 HBG2	7.30e-05	186	167	6	34ed60e846fd83fab3e28dc9e278bcc4b092a9f0
ToppCell	Control-Endothelial-Endothelial-Vein\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 GRID2 LRP1B ZFPM2 PRCP NFE2L1	7.30e-05	186	167	6	92092f11ecce22c14f244e42c499af0822977e6f
ToppCell	PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD PKHD1L1 HBB HBG1 HBG2	7.30e-05	186	167	6	6078aa16261554c7fd41137b8de1362d15b30490
ToppCell	3'_v3-bone_marrow-Hematopoietic_Erythro-Mega\|bone_marrow / Manually curated celltypes from each tissue	TRIM58 ZFPM2 HBB HBD HBG1 HBG2	7.30e-05	186	167	6	9ff3c30b1728707bb8f9422941333fe3b2c430f4
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD CNPPD1 HBB HBG1 HBG2	7.30e-05	186	167	6	40acd9b4e9b3c1d1527bd4ba17ae830ff18d6e9d
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EHD3 TXK AHNAK CHPF CTSW TECPR1	7.30e-05	186	167	6	e23e1246914e230369a716d0d666b98383bf8512
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	COPA ITSN1 EML6 TNRC6B CD163L1 HECTD1	7.52e-05	187	167	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	FMO2 FAT3 GRID2 ZFPM2 SDK1 ANO3	7.52e-05	187	167	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	7.75e-05	188	167	6	f81099b5b3f1f85a28445bc663efcf73baccb2be
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 ANO3 DYNC1I1	7.75e-05	188	167	6	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Red_blood_cells-RBC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRIM58 CNPPD1 HBB HBD HBG1 HBG2	7.75e-05	188	167	6	05b3ade422beeb3db73d350fe192c21bfcfef188
ToppCell	PCW_10-12-Hematologic_ErythroMegGranulo\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRIM58 HBD ARHGAP30 HBB HBG1 HBG2	7.75e-05	188	167	6	adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 SDK1 ANO3	7.98e-05	189	167	6	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|World / Lineage, cell class and subclass	TRIM58 ITSN1 HBD HBB HBG1 HBG2	7.98e-05	189	167	6	826457adac7477102f86aceb97a8b77929b3e6f9
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 SDK1 ANO3	7.98e-05	189	167	6	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	TRIM58 ITSN1 HBD HBB HBG1 HBG2	8.21e-05	190	167	6	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHAF1A CNTLN BRCA2 EML1 PLOD2 FOXJ1	8.21e-05	190	167	6	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	droplet-Marrow-nan-21m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF8 SLC35C1 TEP1 PRCP AHNAK HSD17B4	8.21e-05	190	167	6	6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGSF8 CNKSR1 PKHD1L1 EDEM2 CHID1 CHPF	8.21e-05	190	167	6	f85cdd79eefd699ada7a91bf4997cc730a9b9846
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FBXO2 LCTL CSPG4 B4GALNT3 CHPF HR	8.45e-05	191	167	6	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP30 STK10 ZDHHC20 TIAM1 PLCB2 TET3	8.45e-05	191	167	6	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 ANO3 DYNC1I1	8.70e-05	192	167	6	24e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell	10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	8.95e-05	193	167	6	1e19f80c52833fb21a8d597a3ba2c4ff464c4559
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	TRIM58 ITSN1 HBD HBB HBG1 HBG2	9.21e-05	194	167	6	f0ababe8daa57f6827a3e2e72c884d9e8b2687a3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 CORO6 SDK1	9.21e-05	194	167	6	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 GRID2 ZFPM2 CSPG4 CORO6 SDK1	9.21e-05	194	167	6	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	(2)_Unknown\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TRIM58 ITSN1 HBB HBD HBG2	9.32e-05	121	167	5	6689c9016f29ce6a16824614b6229a71c42babb5
ToppCell	(2)_unknow\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	TRIM58 ITSN1 HBB HBD HBG2	9.32e-05	121	167	5	0090aef3d8a42968828edc637773ef99b2940dde
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A FAT3 MUC19 LRP1B EHD1 WDFY3	9.47e-05	195	167	6	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNA1A FAT3 MUC19 LRP1B EHD1 WDFY3	9.47e-05	195	167	6	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	9.47e-05	195	167	6	4759018a7c016cb2e3df5696f1e5f912c7c9ee17
ToppCell	10x5'v1-week_12-13-Hematopoietic-erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 FN3K MST1 HBB HBG1 HBG2	9.74e-05	196	167	6	0aae78e73d53416d857bdf21f595a0a0a0ba7944
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 FAT3 GRID2 ZFPM2 ANO3 DYNC1I1	9.74e-05	196	167	6	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 FAT3 GRID2 ZFPM2 ANO3 DYNC1I1	9.74e-05	196	167	6	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	9.74e-05	196	167	6	51c48944149a89b98011a50fe81ca6664d5f0d44
ToppCell	10x3'2.3-week_17-19-Hematopoietic\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	9.74e-05	196	167	6	2aeb792e7685e33e3543a6974be790980a41ed8c
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	TRIM58 ITSN1 HBD HBB HBG1 HBG2	9.74e-05	196	167	6	092caba6726d1acd409a8be335100764d0724e64
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	COPA ARHGAP30 JAK3 STK10 PRCP PLCB2	9.74e-05	196	167	6	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	10x3'2.3-week_17-19-Hematopoietic-erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	TRIM58 ITSN1 MST1 HBB HBG1 HBG2	1.00e-04	197	167	6	b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb
ToppCell	mild-Plasmablast\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CNKSR1 PKHD1L1 BRCA2 EDEM2 HERC2 CHPF	1.00e-04	197	167	6	21085d5e27b5a23a241a933058bb89f8a1fcf198
Drug	AC1L3XKM	DECR1 HBB HBD HBG1 HBG2	7.47e-08	16	164	5	CID000123930
Drug	neokyotorphin	DSPP HBB HBD HBG1 HBG2	1.45e-07	18	164	5	CID000122173
Drug	C19565	DECR1 HBB HBD HBG1 HBG2	2.59e-07	20	164	5	CID000107819
Drug	3-iodo-4-hydroxybenzoic acid	CACNA1A HBB HBD HBG1 HBG2	4.35e-07	22	164	5	CID000449473
Drug	1-butyl-3-methylimidazolium hexafluorophosphate	DSPP ADH5 HBB HBD	5.27e-07	10	164	4	CID002734174
Drug	ferric pyrophosphate	DECR1 HBB HBD HBG1 HBG2	6.94e-07	24	164	5	CID000024877
Drug	syntometrine	HBB HBD HBG1 HBG2	8.23e-07	11	164	4	CID011979741
Drug	NFPLP	HBB HBD HBG1 HBG2	8.23e-07	11	164	4	CID006451852
Drug	N-(2-hydroxypropyl)valine	HBB HBD HBG1 HBG2	8.23e-07	11	164	4	CID000130204
Drug	thiohydantoin	DSPP HBB HBD HBG1 HBG2	1.06e-06	26	164	5	CID001274030
Drug	DB07883	ARID4B DECR1 BRCA2 HBB HBD HBG1 HBG2	1.16e-06	75	164	7	CID000446476
Drug	Ferastral	HBB HBD HBG1 HBG2	1.23e-06	12	164	4	CID000171553
Drug	2-hydroxylamino-5-ethyl-5-propylbarbituric acid	HBB HBD HBG1 HBG2	1.23e-06	12	164	4	CID000128182
Drug	7-methylguanosine 5'-phosphate	HBB HBD HBG1 HBG2	1.23e-06	12	164	4	CID000440190
Drug	pentafluorophenyl isothiocyanate	HBB HBD HBG1 HBG2	1.76e-06	13	164	4	CID000123452
Drug	3-aminobiphenyl	HBB HBD HBG1 HBG2	1.76e-06	13	164	4	CID000016717
Drug	dimethyl adipimidate	SPTBN4 HBB HBD HBG1 HBG2	2.25e-06	30	164	5	CID000025738
Drug	6-amino-m-cresol	HBB HBD HBG1 HBG2	2.46e-06	14	164	4	CID000076082
Drug	Prussian blue	PDHB NDUFV1 ADH5 DECR1 PRCP HBB HBD HBG1 HBG2	2.62e-06	161	164	9	CID000025959
Drug	acetylphenylhydrazine	DECR1 HBB HBD HBG1 HBG2	2.66e-06	31	164	5	CID000008247
Drug	flavins	FMO2 CRY2 DECR1 UBE2V1 HBB HBD HBG1 HBG2	2.93e-06	122	164	8	CID005326566
Drug	NMAM	HBB HBD HBG1 HBG2	3.33e-06	15	164	4	CID000013543
Drug	BW12C	HBB HBD HBG1 HBG2	3.33e-06	15	164	4	CID000072162
Drug	methyl acetyl phosphate	HBB HBD HBG1 HBG2	3.33e-06	15	164	4	CID000170449
Drug	1,2,4-tribromobenzene	DECR1 HBB HBD	3.63e-06	5	164	3	CID000012002
Drug	Gm(5')ppp	HBB HBD HBG1 HBG2	4.41e-06	16	164	4	CID000173813
Drug	colupulone	HBB HBD HBG1 HBG2	4.41e-06	16	164	4	CID000373677
Drug	N-(2-hydroxyethyl)valine	HBB HBD HBG1 HBG2	5.74e-06	17	164	4	CID000107912
Drug	Rsr 4	HBB HBD HBG1 HBG2	5.74e-06	17	164	4	CID000131347
Drug	AC1L1BA8	HBB HBD HBG1 HBG2	7.34e-06	18	164	4	CID000001351
Drug	phenylhydroxylamine	DECR1 HBB HBD HBG1 HBG2	7.55e-06	38	164	5	CID000007518
Drug	butadiene monoxide	DECR1 HBB HBD HBG1 HBG2	8.62e-06	39	164	5	CID000013586
Drug	AC1L1G3W	DSPP RYR1 ADH5 DECR1 MST1 HBB HBD HBG1 HBG2 ATP2B1	8.94e-06	237	164	10	CID000003514
Drug	glycidamide	EME1 GRID2 USP40 HBB HBD HBG1 HBG2	9.20e-06	102	164	7	CID000091550
Drug	fructosamine	FN3K CAPN10 HBB HBD PLOD1 HBG1 HBG2	9.20e-06	102	164	7	CID000020484
Drug	Hemorphin 7	HBB HBD HBG1 HBG2	9.24e-06	19	164	4	CID000132952
Drug	1v2w	DECR1 HBB HBD HBG1 HBG2	9.79e-06	40	164	5	CID000131624
Drug	glucitollysine	HBB HBD HBG1 HBG2	1.15e-05	20	164	4	CID000122288
Drug	selenite	RYR1 ADH5 DECR1 SEPHS1 HBB HBD HBG1 HBG2	1.22e-05	148	164	8	CID000001090
Drug	isobutyramide	GRM2 HBB HBD HBG1 HBG2	1.25e-05	42	164	5	CID000068424
Drug	dithionite	ADH5 CRY2 DECR1 HBB HBD HBG1 HBG2 ATP2B1	1.35e-05	150	164	8	CID000001086
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	AVL9 DSPP PDLIM7 SLC35C1 CHAF1A GPRC5C CNPPD1 MIA2 EDEM2	1.41e-05	198	164	9	7174_DN
Drug	S-phenylcysteine	HBB HBD HBG1 HBG2	1.41e-05	21	164	4	CID000119462
Drug	iron phosphate	HBB HBD HBG1 HBG2	1.41e-05	21	164	4	CID000024861
Drug	sitagliptin	DSPP HBB HBD HBG1 HBG2	1.58e-05	44	164	5	CID004369359
Drug	nitrosobenzene	DECR1 HBB HBD HBG1 HBG2	1.58e-05	44	164	5	CID000011473
Drug	N,N-dimethylacrylamide	HSPG2 ZC3HC1 HBB HBD	1.72e-05	22	164	4	CID000017587
Drug	Cilag	HBB HBD HBG1 HBG2	1.72e-05	22	164	4	CID000070549
Drug	tellimagrandin I	HBB HBD HBG1 HBG2	1.72e-05	22	164	4	CID000442690
Drug	NSC69862	HBB HBD HBG1 HBG2	1.72e-05	22	164	4	CID000072284
Drug	iron-nitrosyl	ARID4B HBB HBD HBG1 HBG2	1.77e-05	45	164	5	CID000123668
Drug	propylene oxide	DECR1 HBB HBD HBG1 HBG2	1.97e-05	46	164	5	CID000006378
Drug	Cefotetanum [inn-latin]	CACNA1A HBB HBD HBG1 HBG2	1.97e-05	46	164	5	CID000050614
Drug	L 35	HSD17B4 HBB HBD	2.00e-05	8	164	3	CID000195347
Drug	AC1L8FE9	HBB HBD HBG1 HBG2	2.07e-05	23	164	4	CID000425294
Drug	n-butyl isocyanide	HBB HBD HBG1 HBG2	2.07e-05	23	164	4	CID000076008
Drug	L-histidine beta-naphthylamide	HBB HBD HBG1 HBG2	2.07e-05	23	164	4	CID000110993
Drug	NSC-7813	HBB HBD HBG1 HBG2	2.07e-05	23	164	4	CID000407619
Drug	sodium dithionite	ADH5 DECR1 HBB HBD HBG1 HBG2	2.13e-05	78	164	6	CID000024489
Drug	tetramethylbenzidine	HBB HBD PLOD1 HBG1 HBG2	2.19e-05	47	164	5	CID003034398
Drug	hematin	TG DECR1 HBB HBD HBG1 HBG2	2.84e-05	82	164	6	CID000027337
Drug	heme As	DSPP DECR1 HBB HBD HBG1 HBG2	2.84e-05	82	164	6	CID006323354
Drug	phenylhydrazine	DECR1 SPTBN4 HBB HBD HBG1 HBG2	2.84e-05	82	164	6	CID000007516
Drug	Vv-hemorphin-7	HBB HBD HBG1 HBG2	2.92e-05	25	164	4	CID000126533
Drug	Chlorocruorin	HBB HBD HBG1 HBG2	2.92e-05	25	164	4	CID005748247
Drug	DNME	HBB HBD HBG1 HBG2	3.43e-05	26	164	4	CID005464045
Drug	iron (II) d-gluconate dihydrate	HBB HBD HBG1 HBG2	3.43e-05	26	164	4	CID000071372
Drug	NSC272671	TG PRCP EML1 HBB HBD HBG1 HBG2 CTSW	3.93e-05	174	164	8	CID000004742
Drug	2,7-diaminofluorene	HBB HBD HBG1 HBG2	4.00e-05	27	164	4	CID000010679
Drug	PCMB	DECR1 PRCP ENTPD2 HBB HBD HBG1 HBG2 CTSW	4.62e-05	178	164	8	CID000001730
Drug	selenide ion	TG ADH5 DECR1 SEPHS1 HBB HBD HBG1 HBG2	4.62e-05	178	164	8	CID000107674
Drug	urobilinogen	HBB HBD HBG1 HBG2	4.64e-05	28	164	4	CID000026818
Drug	betamethasone valerate	HBB HBD HBG1 HBG2	4.64e-05	28	164	4	CID000016533
Drug	tricapryl(methyl)ammonium	HBB HBD	5.16e-05	2	164	2	CID011071504
Drug	ethyl 4-cyanobenzoylformate	ADH5 DECR1	5.16e-05	2	164	2	CID004065229
Drug	allyl 2,4,6-tribromophenyl ether	HBB HBD	5.16e-05	2	164	2	CID000076767
Drug	1,3,5-tribromobenzene	HBB HBD	5.16e-05	2	164	2	CID000012279
Drug	2-nitroso-1-naphthol-4-sulfonic acid	DSPP DECR1	5.16e-05	2	164	2	CID000077257
Drug	2-(alpha-hydroxybenzyl)-benzimidazole	HBB HBD	5.16e-05	2	164	2	CID000005792
Drug	NSC-334295	HBB HBD	5.16e-05	2	164	2	CID000100107
Drug	AC1L3OJQ	HBB HBD	5.16e-05	2	164	2	CID000119294
Drug	pentabromobenzene	HBB HBD	5.16e-05	2	164	2	CID000011854
Drug	tribromobenzene	HBB HBD	5.16e-05	2	164	2	CID000011842
Drug	Bromkal 73-5 PE	HBB HBD	5.16e-05	2	164	2	CID000118216
Drug	potassium ferricyanide	DECR1 HBB HBD HBG1 HBG2	5.18e-05	56	164	5	CID000026250
Drug	Lvv-hemorphin-7	HBB HBD HBG1 HBG2	5.36e-05	29	164	4	CID000126532
Drug	hydroxyacetophenone	RYR1 ADH5 DECR1	5.80e-05	11	164	3	CID000068490
Drug	NSC334284	HBB HBD HBG1 HBG2	6.14e-05	30	164	4	CID000100101
Drug	trimidox	HBB HBD HBG1 HBG2	7.02e-05	31	164	4	CID005464467
Drug	AC1LA5IX	HBB HBD HBG1 HBG2	7.02e-05	31	164	4	CID000462147
Drug	GDP-Man	MAN2A1 SLC35C1 ARFGEF1 DECR1 TSR1 B4GALNT3 ANO3	7.12e-05	140	164	7	CID000000732
Drug	1,3-butadiene	DECR1 HBB HBD HBG1 HBG2	7.23e-05	60	164	5	CID000007845
Drug	p-nitrophenacyl bromide	DECR1 HBB HBD	7.70e-05	12	164	3	CID000066840
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KIF13B IPP PTK6 CNPPD1 TIAM1 TSR1 WBP4 KIF1C	8.45e-05	194	164	8	5316_DN
Drug	styrene oxide	DECR1 HBB HBD HBG1 HBG2	8.47e-05	62	164	5	CID000007276
Drug	ferric citrate	DECR1 HBB HBD HBG1 HBG2	8.47e-05	62	164	5	CID000031083
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A	CACNA1A DSPP PDLIM7 PTK6 EHD3 TIAM1 BRCA2 HR	8.76e-05	195	164	8	6662_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	CENPB PDLIM7 CNPPD1 MIA2 BRCA2 NUDT1 EML1 KIF1C	9.08e-05	196	164	8	1794_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	HSPG2 CENPB CHAF1A WRAP53 TEP1 CRY2 CNPPD1 TSR1	9.08e-05	196	164	8	1323_UP
Drug	GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A	HSPG2 DGKE PTK6 CRY2 CNPPD1 EHD1 MRNIP KIF1C	9.08e-05	196	164	8	7092_UP
Disease	Delta-Beta Thalassemia	HBB HBD HBG1	1.54e-07	3	159	3	C0271985
Disease	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	HBB HBG1 HBG2	1.54e-07	3	159	3	141749
Disease	Hereditary persistence of fetal hemoglobin	HBB HBG1 HBG2	1.54e-07	3	159	3	cv:C0019025
Disease	delta beta-thalassemia (is_implicated_in)	HBB HBG1 HBG2	1.54e-07	3	159	3	DOID:0080773 (is_implicated_in)
Disease	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	HBB HBG1 HBG2	6.12e-07	4	159	3	C1841621
Disease	Chloracne	AHNAK HBB HBD HBG1	2.94e-05	33	159	4	C0263454
Disease	Hemoglobin F Disease	HBB HBG1 HBG2	6.66e-05	15	159	3	C0019025
Disease	Sarcomatoid Renal Cell Carcinoma	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	7.03e-05	128	159	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	7.03e-05	128	159	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	7.03e-05	128	159	6	C1266044
Disease	Papillary Renal Cell Carcinoma	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	7.03e-05	128	159	6	C1306837
Disease	Renal Cell Carcinoma	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	7.03e-05	128	159	6	C0007134
Disease	beta thalassemia (implicated_via_orthology)	HBB HBD	8.63e-05	3	159	2	DOID:12241 (implicated_via_orthology)
Disease	Thromboembolism	HBD HBD HBG1 HBG2	9.32e-05	44	159	4	HP_0001907
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	SHANK1 PDHB LRP1B RYR1 SPTBN4 AHNAK	1.56e-04	148	159	6	C0279702
Disease	response to calcium channel blocker	TRIM58 MUC19 GRM2 TIAM1	2.40e-04	56	159	4	EFO_0007767
Disease	hemoglobin measurement, hemoglobin A2 measurement	HBD HBD	2.85e-04	5	159	2	EFO_0004509, EFO_0005845
Disease	galectin-7 measurement	ZFPM2 MST1	4.27e-04	6	159	2	EFO_0022034
Disease	hemoglobin E disease	HBD HBD	4.27e-04	6	159	2	MONDO_0016243
Disease	anemia (biomarker_via_orthology)	HBB HBD	5.95e-04	7	159	2	DOID:2355 (biomarker_via_orthology)
Disease	CMRF35-like molecule 6 measurement	GPRC5C ATP2B1	7.91e-04	8	159	2	EFO_0008086
Disease	Alzheimer disease, fasting blood glucose measurement	SLC35C1 CRY2	1.01e-03	9	159	2	EFO_0004465, MONDO_0004975
Disease	PRADER-WILLI SYNDROME	MKRN3 HERC2	1.26e-03	10	159	2	176270
Disease	Prader-Willi syndrome	MKRN3 HERC2	1.26e-03	10	159	2	cv:C0032897
Disease	high grade glioma (is_implicated_in)	CHAF1A BRCA2 ENTPD2	1.51e-03	42	159	3	DOID:3070 (is_implicated_in)
Disease	non-high density lipoprotein cholesterol measurement	CACNA1A KIF13B CNKSR1 PNLIPRP2 PDHB DGKQ BRCA2 CD163L1 NYNRIN B4GALNT3 HBB	1.74e-03	713	159	11	EFO_0005689
Disease	Royer Syndrome	MKRN3 HERC2	1.84e-03	12	159	2	C0265222
Disease	advanced glycosylation end product-specific receptor, soluble measurement	ZFPM2 B4GALNT3	2.16e-03	13	159	2	EFO_0020131
Disease	Prader-Willi Syndrome	MKRN3 HERC2	2.16e-03	13	159	2	C0032897
Disease	response to olanzapine	IGSF8 ZFPM2	2.89e-03	15	159	2	GO_0097333
Disease	hepcidin:transferrin saturation ratio	PDHB EML6	2.89e-03	15	159	2	EFO_0007902
Disease	X-17654 measurement	PNLIPRP2 HSD17B4	2.89e-03	15	159	2	EFO_0800784
Disease	interleukin 12 measurement	GRID2 GPRC5C ZFPM2	2.95e-03	53	159	3	EFO_0004753
Disease	cochlin measurement	ZFPM2 NFE2L1	3.29e-03	16	159	2	EFO_0801481
Disease	Cannabis use	CHID1 SDK1	3.29e-03	16	159	2	EFO_0007585
Disease	sickle cell anemia (is_implicated_in)	HBB HBG2	3.29e-03	16	159	2	DOID:10923 (is_implicated_in)
Disease	copine-1 measurement	EDEM2 CPNE1	3.72e-03	17	159	2	EFO_0008102
Disease	aspartate aminotransferase measurement	TNFSF12 PDHB MUC19 IPP HKDC1 TXK ADH5 NFE2L1 WBP4 EDEM2 CPNE1 WDR41	3.73e-03	904	159	12	EFO_0004736
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	TNRC6B ZFPM2	4.17e-03	18	159	2	EFO_1000649, HP_0000131
Disease	primary ciliary dyskinesia (implicated_via_orthology)	CBY1 FOXJ1	4.65e-03	19	159	2	DOID:9562 (implicated_via_orthology)
Disease	serum carcinoembryonic antigen measurement	LMTK3 HSD17B4	5.14e-03	20	159	2	EFO_0005760

Protein segments in the cluster

Peptide	Gene	Start	Entry
EQPGFWEGEAERGKA	CACNA1A	911	O00555
GGFDNIESGAVWKQV	ARID4B	351	Q4LE39
ADIVQGKGEAALWGE	ERICH3	786	Q5RHP9
GAWNETKEILGPEGG	PABPN1L	31	A6NDY0
VGEGKSIGEWFGPNT	ATG4A	136	Q8WYN0
RWNGFGGKVQEGETI	NUDT1	31	P36639
ELQKQGAGGVEGAEW	CSPG4	711	Q6UVK1
DESDKIWVGEEGSGG	CNTLN	51	Q9NXG0
ARGWQGIDPAGGEEV	B4GALNT3	731	Q6L9W6
WGVSVVVGVAASGEE	ADH5	286	P11766
FVGLGLVGGNVDWKQ	ARFGEF1	1091	Q9Y6D6
VSGQEAKEPESWDGG	ARHGEF5	371	Q12774
IFEDLQAAVKWGGAG	C20orf204	41	A0A1B0GTL2
GWGALESVVAGSEGA	GRM2	296	Q14416
NGQWIAETGVSGGVD	CBY1	56	Q9Y3M2
VSGQEAKEPESWDGG	ARHGEF35	371	A5YM69
GDGTVGWVLGALEET	DGKQ	646	P52824
KAEASIQAGAGDGEW	AHNAK	5686	Q09666
NEEGNIEGWNGDTGK	DSPP	101	Q9NZW4
WAGQVADALVDLTGG	CAPN10	166	Q9HC96
VGDHFGKGNGLTWAE	CD163L1	846	Q9NR16
EQDSWSEAGGILFKG	CHAF1A	221	Q13111
ADEIGKLFVGGLDWS	DAZAP1	6	Q96EP5
EGEGETGWIEGAAIL	ATP2B1	146	P20020
ATDIGIWLGILEGIG	ANO3	806	Q9BYT9
GGGAAVQWSRVEEGV	ISLR2	536	Q6UXK2
GEQDTWAGEGAEALA	NFE2L1	211	Q14494
DKGLGGLVWQGQVAE	RBFA	256	Q8N0V3
DGWVFVELDVGSEGN	HSPG2	141	P98160
GLLLWQGVEVGEAGQ	HSPG2	4241	P98160
LQQGDIKLEEGWGGV	RAB42	181	Q8N4Z0
GGWVGAEIGNTIERF	IPP	396	Q9Y573
LRVAGDGGIAWTQGE	JAK3	271	P52333
EAKGGGVVSVVWEGL	PALM3	211	A6NDB9
RGIVEVVWEGVGGSD	PALM3	271	A6NDB9
VVWEGVGGSDAEAMG	PALM3	276	A6NDB9
QGGSGGEEGSFIWVE	PALM3	331	A6NDB9
AGSTWADPQEKGQGG	ZFYVE28	426	Q9HCC9
QDSGGSEVAWGPQKG	MRNIP	166	Q6NTE8
TVEGGWPQFGVGAEI	PDHB	291	P11177
LGGVQRALQEELWGG	KRBA1	1006	A5PL33
SGWDVEKGNAGGIQP	NAXE	221	Q8NCW5
GLGRVEGIAVDWIAG	LRP1B	1951	Q9NZR2
DNPDGGVWKQGFDIT	MAN2A1	141	Q16706
GEEPVAGVWSEKGQV	GRWD1	161	Q9BQ67
VALVQGWALGGGAEF	ECHDC1	151	Q9NTX5
WGKGDNQRLGHGTEE	HERC2	681	O95714
ALTVDGKVFSWGEGD	HERC2	3061	O95714
GSLQPGEFDVWGEGA	IHO1	311	Q8IYA8
DWDGPGELEVFQKDG	ZFPM2	96	Q8WW38
GKGLEWVSAIGTAGD	IGHV3-13	61	P01766
GPGSGVDAKAGWVDN	LMTK3	1126	Q96Q04
WAQAGKEVAVGDSEG	DYNC1I1	586	O14576
VLTGKWVAQDAGIGA	EDEM2	241	Q9BV94
WGTEALGALGGQVQA	HR	886	O43593
GARILSGQEEGVFGW	ENTPD2	156	Q9Y5L3
EDGTWNGLVGELVFK	GRID2	501	O43424
SGQVAVPQDSDGGGW	FBXO2	236	Q9UK22
WRGELQEEGAVGGAA	PCNX3	556	Q9H6A9
EGGGEWVGPSEEELF	KIAA0232	1376	Q92628
QTEGAWDQDGKGPSI	LCTL	51	Q6UWM7
GAEGAEWTLAGTGQE	LENG9	191	Q96B70
DVGFGWGISDEKGLE	MUC19	206	Q7Z5P9
DDGRVYEGVGWNIQG	PGLYRP3	91	Q96LB9
VGDDGRVYEGVGWNI	PGLYRP4	121	Q96LB8
NGELDPWSGGGVTKD	PRCP	426	P42785
RDVWDTVGEEEGGGA	KIF1C	801	O43896
QEIGNGWFGKVLLGE	LMTK2	141	Q8IWU2
AGATWGNGSGEEEEE	GNL1	316	P36915
GWFGEGILTGNEKET	KRT35	86	Q92764
GAAPGQQEESWGGSV	MSL1	86	Q68DK7
GGKAAQAGVAVGDWV	PDLIM7	36	Q9NR12
QAGVAVGDWVLSIDG	PDLIM7	41	Q9NR12
VGDWVLSIDGENAGS	PDLIM7	46	Q9NR12
VKVLGQGEEWRGGDG	PLOD2	66	O00469
GEDWNVEKGTSAGGG	PLOD1	61	Q02809
WATLLDEAGGAVAQG	PTK6	46	Q13882
SGAWGIVLEAVAGAG	GPRC5C	46	Q9NQ84
LQKEDGSFAGDIWGE	RABGGTB	126	P53611
VLEWGAEGVAGKSGL	FCHSD1	311	Q86WN1
WINGAVIKFDGGEEV	DECR1	291	Q16698
IIIGGFWLGVDQEGA	SLC35C1	176	Q96A29
EEVFNDEWGAAGGVA	CNPPD1	141	Q9BV87
LEAEDWAQGVVEAGG	CENPB	471	P07199
QGEGTVTGELHNGWI	HECTD1	1296	Q9ULT8
EEGVVLEAVAWLAGG	IGSF8	436	Q969P0
ESLWTGKGIQLADGG	BRCA2	2571	P51587
TEGLGPAVWQGGETE	CRY2	221	Q49AN0
GKGQEEGGGWDVEED	COPA	871	P53621
LAEAGWTAEGRVVGV	DHX35	91	Q9H5Z1
EENGGLFEVGAGWIG	HSD17B4	231	P51659
ENRDDVFLDGTGWEG	AVL9	486	Q8NBF6
AIDWGDFGVEAVSEG	CDK5RAP3	266	Q96JB5
GGDGIDWGDDAVALQ	CDK5RAP3	306	Q96JB5
ESQTGEPGWLGGELK	ITSN1	776	Q15811
WGKVNVEDAGGETLG	HBG1	16	P69891
GWDAGTENKGVDDPG	FAT3	4306	Q8TDW7
VGFGSVKSEEGIWAE	CTSW	296	P56202
WEAIFDAGTLGGELG	FOXJ1	311	Q92949
GGDNVIIIWNVGTGE	CORO6	151	Q6QEF8
DIGGVWRFKENVEDG	FMO2	36	Q99518
GVWPEGSDGTDINAV	EML1	731	O00423
FVTGGKDGIVALWDD	EML5	916	Q05BV3
FVTGGKDGIVELWDD	EML6	916	Q6ZMW3
LESDWAGGVKVDLAG	EME1	461	Q96AY2
WGKVNVDAVGGEALG	HBD	16	P02042
WGKVNVDEVGGEALG	HBB	16	P68871
VWSEIGKGFLDGSLD	CYP20A1	201	Q6UW02
VCGGDGTVGWVLDAV	DGKE	276	P52429
GWGETKGTGNDTVLN	MST1	606	P26927
WGKVNVEDAGGETLG	HBG2	16	P69892
YGEGAGEGIDDVEWV	EHD1	426	Q9H4M9
SRWIVEGQVGAIGDE	SDK1	1101	Q7Z5N4
DGLAVDTGVDVWAFG	SBK1	226	Q52WX2
EAGGEFWGELEVQRV	RYR1	4536	P21817
RELGVGVSIWELGQG	CHID1	371	Q9BWS9
VLLQDVGGGSWAELG	CPNE1	31	Q99829
DIDGIWEGIGGFVSC	PNLIPRP2	266	P54317
GVQTEAGVADLTWVG	WDR77	76	Q9BQA1
VDTLAKQGAQGGGQW	NYNRIN	1441	Q9P2P1
GQGGEEQACWEVGED	ARHGAP30	646	Q7Z6I6
SGVKEWFGLGGEQAE	MIA2	221	Q96PC5
WFGLGGEQAEEKAFE	MIA2	226	Q96PC5
GPADFQEGTWVGVEL	KIF13B	1721	Q9NQT8
DELWKGALAETGAGA	MRPS5	96	P82675
AVSVWDTDGPGNDGK	WRAP53	436	Q9BUR4
TEWGGFGDNGCIDDI	HKDC1	706	Q2TB90
LTGTGGALVNDEGWI	TAF1L	86	Q8IZX4
EKHAGGVTGGWDNLL	NDUFV1	301	P49821
GDLWSGNVAEDDVGP	FN3K	216	Q9H479
GEGHQAWIIGIVEKG	SEPHS1	346	P49903
GAEGIINVAQEGVWD	CCT8L1P	481	A6NM43
GTEGIINVAQEGVWD	CCT8L2	481	Q96SF2
ITRGQDEASAGGIWG	PRRC1	201	Q96M27
SGVDVGGQHEWGELV	SUPT5H	526	O00267
YGEGAGEGIDDAEWV	EHD3	426	Q9NZN3
IKVLSIGEGGFWEGQ	SHANK1	581	Q9Y566
IGEGGFWEGQVKGRV	SHANK1	586	Q9Y566
VGGFDVSIQGWGLED	CHSY1	706	Q86X52
REKPGAGEGAGENWE	CHPF	71	Q8IZ52
SEGLGAWGVAQAEGS	CNKSR1	666	Q969H4
EGQAFAVGVEKNWGA	ZC3HC1	6	Q86WB0
GEGHQAWIVGIVEKG	SEPHS2	396	Q99611
WLENGAEEGIVKSGT	ZDHHC20	341	Q5W0Z9
QAEWILDGGSQSGGE	TSR1	401	Q2NL82
ETRDWGGAQFEGEKG	ZSWIM9	501	Q86XI8
WDIGGRKGTAIELQG	WDFY2	226	Q96P53
EGLSGGGWLEQTDSV	WDFY3	1706	Q8IZQ1
KVLVSGAEDGSLQGW	TEP1	1981	Q99973
GGGDTDRWVEEQFDL	TIAM1	1476	Q13009
AAGGAGVESWADAIE	MKRN3	191	Q13064
EAVKVLSIGEGGFWE	SHANK3	496	Q9BYB0
LSIGEGGFWEGTVKG	SHANK3	501	Q9BYB0
TQPELGTWGDGKGED	STX18	211	Q9P2W9
GTWGDGKGEDELSPE	STX18	216	Q9P2W9
VDFSVPGGTDQEGWQ	TECPR1	876	Q7Z6L1
AEVQEVVWGEGAGAG	SLC12A9	796	Q9BXP2
VVWGEGAGAGEPEAE	SLC12A9	801	Q9BXP2
WEIVGELGDGAFGKV	STK10	36	O94804
EPGGIGVGEKDWTSD	TNKS1BP1	1216	Q9C0C2
GQTDWSGVEAGEFLK	TNKS1BP1	1256	Q9C0C2
GASQWEKPEGFQGDL	WBP4	146	O75554
LEEGQKGVGDGTVSW	UBE2V1	21	Q13404
KGVGDGTVSWGLEDD	UBE2V1	26	Q13404
QGAEELGAEWGALAS	SPTBN4	1061	Q9H254
EATWGVSSENGGGLE	PPP1R3F	456	Q6ZSY5
ISLQGGRLIGGWEDN	PKHD1L1	3106	Q86WI1
EVEIKAGEGAGPWGQ	TET3	101	O43151
KGGGGAEEEEEELWS	TET3	1626	O43151
GGDKAVVLWDVASGQ	WDR83	86	Q9BRX9
AGEGTVWAGEEGTEL	PLCB2	491	Q00722
GESDGEDGAWQGSQL	PPP6R1	636	Q9UPN7
EIGSGQFGVVHLGEW	TXK	276	P42681
EGQKGVGDGTVSWGL	UBE2V2	21	Q15819
GAQAGVDGTVSGWEE	TNFSF12	121	O43508
ESGIVEGAFSGWKVI	TOPBP1	1386	Q92547
GSGEVSGNWGLLDQV	TG	2346	P01266
GEDIFVWNGVEVGGV	USP40	616	Q9NVE5
GDDGIVVVWNAQTGE	WDR41	61	Q9HAD4
LVGEGAEWGLGVCQD	TRIM58	351	Q8NG06
ATAGGDWTEGAGEQE	TEX13B	171	Q9BXU2
SKPVSGWGEGGQNEI	TNRC6B	766	Q9UPQ9